Nader Achackzad, MD | |
1871 Martin Ave Ste 102, Santa Clara, CA 95050-2501 | |
(408) 988-8581 | |
(408) 988-8734 |
Full Name | Nader Achackzad |
---|---|
Gender | Male |
Speciality | Pain Medicine - Interventional Pain Medicine |
Location | 1871 Martin Ave Ste 102, Santa Clara, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831375302 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | A98178 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nader Achackzad, MD 1871 Martin Ave Ste 102, Santa Clara, CA 95050-2501 Ph: (408) 988-8581 | Nader Achackzad, MD 1871 Martin Ave Ste 102, Santa Clara, CA 95050-2501 Ph: (408) 988-8581 |
News Archive
The number of women with high blood pressure when they become pregnant or who have it diagnosed during the first 20 weeks of pregnancy has spiked in the United States over the last four decades, especially among black women, according to new research in the American Heart Association's journal Hypertension.
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
Researchers at the University of Virginia School of Medicine have identified immune cells vital for protecting us from potentially fatal C. difficile infection. Surprisingly, those cells are often vilified for their role in causing asthma and allergies. But when it comes to C. difficile, they could be the difference in life and death.
The genetic pathway that regulates the way cells align themselves relative to each other has been found to act as a "stop sign" that signals organisms when to halt cell growth, according to new research published by biologists at the Center for Regenerative and Developmental Biology in Tufts University's School of Arts and Sciences.
ATS Automation Tooling Systems has announced it has recently received a total of US $10.7 million (CDN $14.2 million) in orders from one of the world's largest manufacturers of self-use medical diagnostic systems.
› Verified 4 days ago